Form 4: Zomedica CEO Larry Heaton II Executes Stock Transaction
SEC Form 4 Filing
Zomedica Corp. CEO Larry Heaton II reports the acquisition and disposition of common stock on September 5, 2024.
Summary
- On September 5, 2024, Larry Heaton II, CEO of Zomedica Corp., engaged in a transaction involving the company's common stock.
- He acquired 100,000 shares of common stock at a price of $0.125 per share.
- Simultaneously, he disposed of 400,000 shares.
- Following these transactions, the reporting person still beneficially owns securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard reporting of stock transactions by an insider. The acquisition could be seen as a positive signal, but the disposition offsets it.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It's common for executives to buy or sell shares for various reasons, including diversification, personal financial planning, or exercising stock options.
Stakeholder Impact
- Shareholders may interpret the CEO's stock transactions as a signal of confidence or lack thereof in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of stock transaction (acquisition and disposition) |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.